NanoViricides Inc. (NNVC)
1.19
-0.13 (-9.85%)
At close: Mar 03, 2025, 3:59 PM
1.18
-0.61%
After-hours: Mar 03, 2025, 06:03 PM EST
NanoViricides Income Statement
| Year | FY24 | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | FY07 | FY06 | FY05 |
| Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost of Revenue | 759.01K | 747.53K | 723.33K | 704.54K | 699.72K | 695.91K | 680.06K | 662.95K | 659.54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Gross Profit | -759.01K | -747.53K | -723.33K | -704.54K | -699.72K | -695.91K | -680.06K | -662.95K | -659.54K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Income | -8.52M | -8.94M | -8.11M | -8.74M | -8M | -8.66M | -9.33M | -9.6M | -8.86M | -7.06M | -8.67M | -6.59M | -6.08M | -6.43M | -4.94M | -2.82M | -2.79M | -3.08M | -2.6M | -66K |
| Interest Income | 221.97K | 355.83K | 11.86K | 9.35K | 17.08K | 55.5K | 100.43K | 60.95K | 62.64K | 160.86K | 171K | 55.59K | 46.79K | 14.34K | n/a | 31.93K | n/a | 54.51K | n/a | n/a |
| Pretax Income | -8.29M | -8.59M | -8.11M | -8.82M | -13.45M | -8.42M | -8.56M | -10.3M | -10.72M | -2.2M | -14.11M | -8.88M | -6.21M | -6.48M | -4.74M | -2,787.8B | n/a | n/a | n/a | n/a |
| Net Income | -8.29M | -8.59M | -8.1M | -8.91M | -13.4M | -8.24M | -8.56M | -10.3M | -10.72M | -2.2M | -14.11M | -8.88M | -6.21M | -6.48M | -4.74M | -2.79M | -2.74M | -3.12M | -3.28M | -66K |
| Selling & General & Admin | 3.08M | 2.55M | 2.33M | 2.63M | 3.3M | 2.74M | 4.5M | 4.07M | 3.83M | 3.4M | 3.54M | 2.3M | 1.82M | 2.27M | 1.74M | 1.09M | 1.95M | 2.35M | 1.7M | 35.23K |
| Research & Development | 5.44M | 6.39M | 5.78M | 6.11M | 4.7M | 5.92M | 4.83M | 5.53M | 5.03M | 3.66M | 5.13M | 4.29M | 4.27M | 4.16M | 3.2M | 1.73M | 839.24K | 731.81K | 899.89K | 30.77K |
| Other Expenses | 0.00 | n/a | n/a | n/a | -142.67K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Operating Expenses | 8.52M | 8.94M | 8.11M | 8.74M | 8M | 8.66M | 9.33M | 9.6M | 8.86M | 7.06M | 8.67M | 6.59M | 6.08M | 6.43M | 4.94M | 2.82M | 2.79M | 3.08M | 2.6M | 66K |
| Interest Expense | n/a | 938.00 | 5.12K | 85.41K | 93.67K | n/a | 544.49K | 2.13M | 2.47M | 3.82M | 3.66M | 1.09M | n/a | n/a | n/a | n/a | n/a | 90.56K | n/a | n/a |
| Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Cost & Expenses | 8.52M | 8.94M | 8.11M | 8.74M | 8M | 8.66M | 9.33M | 9.6M | 8.86M | 7.06M | 8.67M | 6.59M | 6.08M | 6.43M | 4.94M | 2.82M | 2.79M | 3.08M | 2.6M | 66K |
| Income Tax | n/a | 355.83K | -6.74K | 85.41K | -49K | -179.75K | 1.31M | 2.13M | 2.47M | 3.82M | 3.66M | 1.09M | 125.46K | 47.71K | -195.74K | 31.93B | -53.7K | 36.05K | 688.58K | 66K |
| Shares Outstanding (Basic) | 11.87M | 11.63M | 11.53M | 10.9M | 5.62M | 3.59M | 3.25M | 3.01M | 2.88M | 2.83M | 2.56M | 2.29M | 2.14M | 1.99M | 1.86M | 1.71M | 1.67M | 1.6M | 1.48M | 1.43M |
| Shares Outstanding (Diluted) | 11.87M | 11.63M | 11.53M | 10.9M | 5.62M | 3.59M | 3.25M | 3.01M | 2.88M | 2.96M | 2.56M | 2.38M | 2.14M | 1.99M | 1.86M | 1.71M | 1.67M | 1.6M | 1.48M | 1.43M |
| EPS (Basic) | -0.7 | -0.74 | -0.7 | -0.82 | -2.39 | -2.3 | -2.64 | -3.43 | -3.72 | -0.78 | -5.51 | -3.87 | -2.9 | -3.26 | -2.54 | -1.63 | -1.64 | -1.94 | -2.22 | -0.05 |
| EPS (Diluted) | -0.7 | -0.74 | -0.7 | -0.82 | -2.39 | -2.3 | -2.64 | -3.43 | -3.72 | -0.74 | -5.51 | -3.73 | -2.9 | -3.26 | -2.54 | -1.63 | -1.64 | -1.94 | -2.22 | -0.05 |
| EBITDA | -7.76M | -7.84M | -7.38M | -8.03M | -7.3M | -7.96M | -8.59M | -8.94M | -8.2M | -6.76M | -8.46M | -7.56M | -5.99M | -5.95M | -4.65M | -2.83M | -2.73M | -3.03M | -2.55M | -66K |
| Depreciation & Amortization | 759.01K | 747.53K | 723.33K | 704.54K | 699.72K | 695.91K | 680.06K | 662.95K | 659.54K | 302.74K | 212.01K | 219.65K | 219.65K | 527.74K | 90.29K | 12.29K | 13.47K | 36.3K | 44.55K | n/a |